Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BEST: Aripiprazole vs Risperidone in Schizophrenia
NCT00712270Phase 4Terminated
- Sponsor
- Kettering Health
- Start
- Apr 2005
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of aripiprazole, risperidone in schizophrenia, sponsored by Kettering Health. Started Apr 2005; status: terminated.
02
Drugs
aripiprazolerisperidone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00712270.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00712270.